Cancer Research Blog

Bringing You the Latest in the Search For a Cure

Month: January 2017

For Some Breast Cancer Survivors, Drug May Reduce Treatment-Related Joint Pain

A drug most commonly used to treat depression may also reduce joint pain in some women being treated for early-stage breast cancer, according to the results of a randomized clinical trial.

After undergoing treatment for early-stage breast cancer, many postmenopausal women take drugs known as aromatase inhibitors to reduce the risk of the cancer returning. These drugs, however, can cause significant pain in women’s joints and muscles.

FDA Approves Rucaparib for BRCA-Positive Ovarian Cancer

On December 19, the Food and Drug Administration (FDA) granted accelerated approval for rucaparib (Rubraca™) to treat some women with advanced ovarian cancer.

The drug is approved for women whose cancers have progressed despite treatment with two or more chemotherapies and whose tumors have a mutation in the BRCA1 or BRCA2 genes, as identified by an FDA-approved companion diagnostic test. About 15% to 20% of ovarian cancers harbor a BRCA mutation.

Cancer Research Blog © 2016
Contact: jim@jdgblogs.com
Frontier Theme
yes